Consolidated Statement of Cash Flows from 1 January until 31 December 2024
In € thousand |
Notes |
1 – 12/2024 |
1 – 12/2023 |
---|---|---|---|
Profit/(loss) for the period |
|
350,463 |
303,805 |
Amortisation of VBI, impairment of goodwill and other intangible assets, and depreciation of property, plant and equipment |
|
126,457 |
119,471 |
Impairment losses/reversal of impairment losses on other investments |
|
8,202 |
–66,133 |
Gain/(loss) on the disposal of investments |
|
91,834 |
120,502 |
Change in deferred acquisition costs |
|
1,177 |
1,979 |
Change in securities at fair value through profit or loss |
|
–135,492 |
–220,451 |
Change in other receivables |
|
–87,491 |
10,596 |
Change in other liabilities |
|
51,233 |
–2,680 |
Change in technical provisions |
|
135,907 |
104,513 |
Change in defined benefit obligations |
|
–10,793 |
–2,013 |
Change in deferred tax assets and deferred tax liabilities |
|
–6,738 |
19,975 |
Change in other statement of financial position items |
|
55,923 |
–64,260 |
Net cash flow from operating activities |
|
580,683 |
325,304 |
of which from discontinued operations |
|
2,110 |
–102,203 |
|
|
|
|
Proceeds from disposal of intangible assets and property, plant and equipment |
|
5,150 |
6,010 |
Payments for acquisition of intangible assets and property, plant and equipment |
|
–160,578 |
–122,998 |
Payments for acquisition of consolidated companies |
|
–1,577 |
–24,765 |
Proceeds from disposal and maturity of other investments |
|
5,863,610 |
7,396,012 |
Payments for acquisition of other investments |
|
–6,131,202 |
–6,987,634 |
Proceeds from disposal of unit-linked and index-linked life insurance investments |
|
6,513,900 |
4,086,799 |
Payments for acquisition of unit-linked and index-linked life insurance investments |
|
–6,577,262 |
–4,312,470 |
Net cash flow from investing activities |
|
–487,960 |
40,953 |
of which from discontinued operations |
|
–14,701 |
107,668 |
|
|
|
|
Dividend payments |
–177,629 |
–169,441 |
|
Transactions between owners |
|
43,339 |
0 |
Payments from other financing activities |
–19,457 |
–164,252 |
|
Net cash flow from financing activities |
|
–153,747 |
–333,693 |
|
|
|
|
Change in cash and cash equivalents |
|
–61,024 |
32,564 |
of which due to acquisitions of consolidated subsidiaries |
|
23 |
2,794 |
of which from discontinued operations |
|
–12,591 |
5,465 |
Change in cash and cash equivalents due to movements in exchange rates |
|
–1,355 |
–682 |
Cash and cash equivalents at beginning of year |
699,528 |
667,646 |
|
Cash and cash equivalents at end of period |
637,149 |
699,528 |
|
|
|
|
|
Income taxes paid (net cash flow from operating activities) |
|
–70,625 |
–21,660 |
Interest paid (net cash flow from operating activities) |
|
–47,444 |
–56,339 |
Interest received (net cash flow from operating activities) |
|
535,113 |
454,842 |
Dividends received (net cash flow from operating activities) |
|
81,005 |
65,625 |